From page 8. I am puzzled by this paragraph which implies the 'commercial-scale process development' only applies to the titanium products? Are they having difficulty in taking the NdPr into commercial scale?? It certainly seems TiCu is taking precedence over NdPr!
Ann: 2022 Annual Report to Shareholders, page-6
-
- There are more pages in this discussion • 68 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ASM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
61.0¢ |
Change
-0.075(11.0%) |
Mkt cap ! $110.4M | |||
| Open | High | Low | Value | Volume |
| 69.5¢ | 69.5¢ | 60.5¢ | $558.3K | 888.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 42245 | 61.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 62.5¢ | 9026 | 1 |
View Market Depth
| Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
| ASM (ASX) Chart |